Extracorporeal Carbon Dioxide Removal (ECCO2R) in COPD and ARDS Patients with Severe Hypercapnic Respiratory Failure. A Retrospective Case-control Study

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2021 May 2

PMID 33932971

Citations 5

Authors

Volkan Inal

Serdar Efe

Affiliations

Soon will be listed here.

Abstract

Background/aim: Treatment of severe hypercapnic respiratory failure (HRF) has some challenges in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS), especially when lung protective ventilation (LPV) strategies are required. Extracorporeal CO2 removal (ECCO2R) therapy is an emerging option to manage hypercapnia while allowing LPV in these cases. However, further data on ECCO2R use is still needed to make clear recommendations.

Materials And Methods: This study was conducted on patients admitted to intensive care unit (ICU) between January 1st, 2016 to December 31st, 2019. The medical records were retrospectively scanned in institutional software database. Patients who received invasive mechanic ventilation (iMV) support due to severe HRF related to COPD or ARDS were included in the analyses. Patients were grouped according to treatment approaches as that ECCO2R therapy in addition to conventional treatments and conventional treatments alone (controls). Groups were compared for 28-day survival, iMV duration, and length of stay (LOS).

Results: ECCO2R therapy was noted in 75 of the cases among included 395 patients (COPD n = 256, ARDS n = 139) out of scanned 1715 medical records. The survival rate of ECCO2R patients was 68% and significantly higher than 58% survival rate of controls (p = 0.025), with relative risk reduction (RRR) = 0.16, absolute risk reduction (ARR)= 0.10, number need to treat (NNT) = 10, and odds ratio (OR) = 1.5. In addition, iMV duration (12.8 ± 2.6 vs. 17.1 ± 4.9 days, p = 0.007) and LOS (16.9 ± 4.1 vs. 18.9 ± 5.5 days, p = 0.032) were significantly shorter than controls. Repeated measure analyses showed that LPV settings were successfully provided by 72 h of ECCO2R therapy. Subgroup analyses according to diagnoses of COPD and ARDS also favored ECCO2R.

Conclusion: ECCO2R therapy significantly improved survival, iMV duration and LOS in patients with severe HRF due to COPD or ARDS, and successfully provided LPV approaches. Further studies are needed to assess promising benefits of ECCO2R therapy.

Citing Articles

Effects of extracorporeal CO removal on gas exchange and ventilator settings: a systematic review and meta-analysis.

Stommel A, Herkner H, Kienbacher C, Wildner B, Hermann A, Staudinger T Crit Care. 2024; 28(1):146.

PMID: 38693569 PMC: 11061932. DOI: 10.1186/s13054-024-04927-x.

[A case of severe acute respiratory distress syndrome caused by inhalation injury].

Gu C, Li X, Kang X Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(12):1185-1189.

PMID: 38129307 PMC: 11630280. DOI: 10.3760/cma.j.cn501225-20230818-00052.

Extracorporeal carbon dioxide removal for patients with acute respiratory failure: a systematic review and meta-analysis.

Zhou Z, Li Z, Liu C, Wang F, Zhang L, Fu P Ann Med. 2023; 55(1):746-759.

PMID: 36856550 PMC: 9980035. DOI: 10.1080/07853890.2023.2172606.

[Recent research on extracorporeal carbon dioxide removal].

Wang X, Guo Y Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(2):205-209.

PMID: 36854699 PMC: 9979386. DOI: 10.7499/j.issn.1008-8830.2208187.

Extracorporeal Carbon Dioxide Removal: From Pathophysiology to Clinical Applications; Focus on Combined Continuous Renal Replacement Therapy.

Cappadona F, Costa E, Mallia L, Sangregorio F, Nescis L, Zanetti V Biomedicines. 2023; 11(1).

PMID: 36672649 PMC: 9855411. DOI: 10.3390/biomedicines11010142.

References

Taccone F, Malfertheiner M, Ferrari F, Di Nardo M, Swol J, Broman L . Extracorporeal CO2 removal in critically ill patients: a systematic review. Minerva Anestesiol. 2017; 83(7):762-772. DOI: 10.23736/S0375-9393.17.11835-3. View

Fitzgerald M, Millar J, Blackwood B, Davies A, Brett S, McAuley D . Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care. 2014; 18(3):222. PMC: 4056779. DOI: 10.1186/cc13875. View

Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C . Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018; 378(21):1965-1975. DOI: 10.1056/NEJMoa1800385. View

Cummins C, Bentley A, McAuley D, McNamee J, Patrick H, Barrett N . A United Kingdom Register study of in-hospital outcomes of patients receiving extracorporeal carbon dioxide removal. J Intensive Care Soc. 2018; 19(2):114-121. PMC: 5956684. DOI: 10.1177/1751143717739816. View

Barrett N, Hart N, Camporota L . In vivo carbon dioxide clearance of a low-flow extracorporeal carbon dioxide removal circuit in patients with acute exacerbations of chronic obstructive pulmonary disease. Perfusion. 2020; 35(5):436-441. DOI: 10.1177/0267659119896531. View

Sklar M, Beloncle F, Katsios C, Brochard L, Friedrich J . Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med. 2015; 41(10):1752-62. DOI: 10.1007/s00134-015-3921-z. View

Moss C, Galtrey E, Camporota L, Meadows C, Gillon S, Ioannou N . A Retrospective Observational Case Series of Low-Flow Venovenous Extracorporeal Carbon Dioxide Removal Use in Patients with Respiratory Failure. ASAIO J. 2016; 62(4):458-62. DOI: 10.1097/MAT.0000000000000386. View

P Hilty M, Riva T, Cottini S, Kleinert E, Maggiorini A, Maggiorini M . Low flow veno-venous extracorporeal CO2 removal for acute hypercapnic respiratory failure. Minerva Anestesiol. 2017; 83(8):812-823. DOI: 10.23736/S0375-9393.17.11524-5. View

Nin N, Muriel A, Penuelas O, Brochard L, Lorente J, Ferguson N . Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med. 2017; 43(2):200-208. PMC: 5630225. DOI: 10.1007/s00134-016-4611-1. View

10.

Peek G, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany M . Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009; 374(9698):1351-63. DOI: 10.1016/S0140-6736(09)61069-2. View

11.

Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N . Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009; 302(17):1888-95. DOI: 10.1001/jama.2009.1535. View

12.

Kolobow T, Gattinoni L, Tomlinson T, Pierce J . Control of breathing using an extracorporeal membrane lung. Anesthesiology. 1977; 46(2):138-41. DOI: 10.1097/00000542-197702000-00012. View

13.

Patel B, Chatterjee S, DAvignon S, Herlihy J . Extracorporeal membrane oxygenation as rescue therapy for severe hypoxemic respiratory failure. J Thorac Dis. 2019; 11(Suppl 14):S1688-S1697. PMC: 6783730. DOI: 10.21037/jtd.2019.05.73. View

14.

Brower R, Matthay M, Morris A, Schoenfeld D, Thompson B, Wheeler A . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-8. DOI: 10.1056/NEJM200005043421801. View

15.

Combes A, Fanelli V, Pham T, Ranieri V . Feasibility and safety of extracorporeal CO removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. 2019; 45(5):592-600. DOI: 10.1007/s00134-019-05567-4. View

16.

Romay E, Ferrer R . Extracorporeal CO2 removal: Technical and physiological fundaments and principal indications. Med Intensiva. 2015; 40(1):33-8. DOI: 10.1016/j.medin.2015.06.001. View

17.

Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S . The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med. 2016; 42(9):1437-44. DOI: 10.1007/s00134-016-4452-y. View

18.

Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A . Feasibility and safety of low-flow extracorporeal CO removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Crit Care. 2018; 22(1):122. PMC: 5944133. DOI: 10.1186/s13054-018-2038-5. View

19.

Morimont P, Batchinsky A, Lambermont B . Update on the role of extracorporeal CO₂ removal as an adjunct to mechanical ventilation in ARDS. Crit Care. 2015; 19:117. PMC: 4360937. DOI: 10.1186/s13054-015-0799-7. View

20.

Combes A, Auzinger G, Capellier G, Du Cheyron D, Clement I, Consales G . ECCOR therapy in the ICU: consensus of a European round table meeting. Crit Care. 2020; 24(1):490. PMC: 7412288. DOI: 10.1186/s13054-020-03210-z. View